MedPath

Ongoing Registry of Treatment of Venous Thromboembolism

Recruiting
Conditions
Thromboses, Venous
Deep Vein Thrombosis
Pulmonary Embolism
Thrombosis Embolism
Postthrombotic Syndrome
Registration Number
NCT03881345
Lead Sponsor
Medalp Private Surgery Clinic
Brief Summary

Ongoing registration of patients with venous thromboembolism treated by means of antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.

Detailed Description

Data of patients with VTE treated in different Russian medical centers are entered in a prospective digital database, and continuously updated.

There is planned to conduct prospective randomized, cohort and observational studies on the site of register

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • case of venous thrombosis of a limb or pulmonary embolus
Exclusion Criteria
  • no exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Veins patencyBaseline, 3 and 12 months post-intervention

Change in patency target veins assessed by duplex ultrasonography in different follow up periods due to different treatment methods

Secondary Outcome Measures
NameTimeMethod
QoL SF-36Baseline, 3 and 12 months post-intervention

Change in Quality of Life (QoL), assessed by "Short form 36" health survey (SF-36). Total scale range: from 0 to 800. SF-36 consists of 8 subscales. Each subscale range: 0 - 100. Subscales are combined using a special algorithm described in the instructions for the SF-36. For total scale the higher value represent the worse QoL.

Postthrombotic syndromeBaseline, 3 and 12 months post-intervention

the presence and severity of postthrombotic syndrome on the Villalta scale

QoL AVVQBaseline, 3 and 12 months post-intervention

Change in Quality of Life (QoL), assessed by "Aberdeen Varicose Vein Questionnaire" (AVVQ). The AVVQ is a disease-specific QoL questionnaire aimed at venous disease. Total scale range: from 0 to 100, where the higher score represent worse QoL.

Trial Locations

Locations (1)

Pirogov Russian National Research Medical University

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath